Premium
Immupharma Plc (IMM.GB)
AQSE
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Immupharma PLC 28 December 2023 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...
Immupharma PLC 19 December 2023 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...
Immupharma PLC 19 December 2023 19 December 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") Simbec-Orion appointed as CRO | Decision to move directly into a Phase 3...
Immupharma PLC 18 December 2023 18 December 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") Incanthera Secures Commercial Skincare Deal & GBP1M Fundraise ImmuPharma...
Immupharma PLC 13 September 2023 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...
Immupharma PLC 07 September 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA...
Immupharma PLC 06 September 2023 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format...
Immupharma PLC 31 August 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH...
Immupharma PLC 31 August 2023 31 August 2023 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...
Immupharma PLC 31 August 2023 RNS: RELEASE | 31 August 2023 ImmuPharma PLC ("ImmuPharma" or the "Company") INTERIM RESULTS for the six months ended 30 June 2023 ImmuPharma PLC...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.979 | 56.5428571429 | 3.5 | 7.3 | 3.3 | 2963396 | 5.27542174 | DE |
| 4 | 4.229 | 338.32 | 1.25 | 7.3 | 1.2254 | 2468618 | 4.0475653 | DE |
| 12 | 3.879 | 242.4375 | 1.6 | 7.3 | 0.9327 | 896050 | 3.95831315 | DE |
| 26 | 3.479 | 173.95 | 2 | 7.3 | 0.9327 | 419666 | 3.81638477 | DE |
| 52 | 3.954 | 259.278688525 | 1.525 | 7.3 | 0.8544 | 281420 | 3.33664633 | DE |
| 156 | -2.521 | -31.5125 | 8 | 9.33 | 0.8544 | 159341 | 3.4761169 | DE |
| 260 | -8.971 | -62.0830449827 | 14.45 | 18.98 | 0.8544 | 155451 | 5.79764968 | DE |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
